These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 29423956
1. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study. Becskei C, Cuppens O, Mahabir SP. Vet Dermatol; 2018 Jun; 29(3):203-e72. PubMed ID: 29423956 [Abstract] [Full Text] [Related]
2. Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study. Becskei C, Cuppens O, Mahabir SP. Vet Dermatol; 2018 Apr; 29(2):100-e39. PubMed ID: 29392787 [Abstract] [Full Text] [Related]
3. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs. Becskei C, De Bock F, Illambas J, Cherni JA, Fourie JJ, Lane M, Mahabir SP, Six RH. Vet Parasitol; 2016 May 30; 222():56-61. PubMed ID: 26928658 [Abstract] [Full Text] [Related]
4. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States. Vatta AF, Myers MR, Rugg JJ, Chapin S, Pullins A, King VL, Rugg D. Vet Parasitol; 2019 Jun 30; 270 Suppl 1():S3-S11. PubMed ID: 30579753 [Abstract] [Full Text] [Related]
5. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes. Paterson TE, Halliwell RE, Fields PJ, Louw ML, Ball G, Louw J, Pinckney R. Vet Parasitol; 2014 Oct 15; 205(3-4):687-96. PubMed ID: 25262617 [Abstract] [Full Text] [Related]
6. Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis. Fourie JJ, Meyer L, Thomas E. Parasit Vectors; 2019 Jan 25; 12(1):59. PubMed ID: 30683143 [Abstract] [Full Text] [Related]
7. A European field assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosis. Petersen I, Chiummo R, Zschiesche E, Karas-Tecza J, Rapti D, Roepke R, Thomas E. Parasit Vectors; 2020 Jun 11; 13(1):304. PubMed ID: 32527282 [Abstract] [Full Text] [Related]
8. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Heine J, Krieger K, Dumont P, Hellmann K. Parasitol Res; 2005 Oct 11; 97 Suppl 1():S89-S96. PubMed ID: 16228281 [Abstract] [Full Text] [Related]
9. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Fourie JJ, Liebenberg JE, Horak IG, Taenzler J, Heckeroth AR, Frénais R. Parasit Vectors; 2015 Mar 28; 8():187. PubMed ID: 25881320 [Abstract] [Full Text] [Related]
10. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis. Six RH, Becskei C, Mazaleski MM, Fourie JJ, Mahabir SP, Myers MR, Slootmans N. Vet Parasitol; 2016 May 30; 222():62-6. PubMed ID: 26971196 [Abstract] [Full Text] [Related]
11. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study. Krieger K, Heine J, Dumont P, Hellmann K. Parasitol Res; 2005 Oct 30; 97 Suppl 1():S81-S88. PubMed ID: 16228280 [Abstract] [Full Text] [Related]
20. Efficacy and safety of a new spot-on formulation of selamectin plus sarolaner in the treatment of naturally occurring flea and tick infestations in cats presented as veterinary patients in Europe. Geurden T, Becskei C, Farkas R, Lin D, Rugg D. Vet Parasitol; 2017 Apr 30; 238 Suppl 1():S12-S17. PubMed ID: 28395750 [Abstract] [Full Text] [Related] Page: [Next] [New Search]